Globus Medical Inc. (GMED)
72.23
-0.75 (-1.03%)
At close: Apr 15, 2025, 3:59 PM
72.35
0.17%
After-hours: Apr 15, 2025, 05:05 PM EDT
Globus Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emerging Technology Revenue | 83.73M | 38.3M | 31.97M | 32.71M | 27.66M | 34.76M | 25.08M | 29.5M | 24.09M | 29.41M | 13.15M | 25.4M | 20.24M | 20.75M | 14.93M | 18.08M | 9.04M | 5.44M | 8.04M | 13.91M | 13.89M | 19.19M | 7.19M | 6.28M | 13.81M | 12.78M |
| Emerging Technology Revenue Growth | +118.60% | +19.81% | -2.28% | +18.27% | -20.42% | +38.59% | -14.98% | +22.46% | -18.08% | +123.67% | -48.24% | +25.47% | -2.46% | +39.02% | -17.45% | +100.15% | +66.02% | -32.27% | -42.24% | +0.14% | -27.61% | +166.94% | +14.40% | -54.51% | +8.06% | n/a |
| Spine Revenue | 1.2B | 587.4M | 574.7M | 592.34M | 347.46M | 256.86M | 251.61M | 245M | 230.06M | 234.24M | 217.4M | 224.62M | 209.48M | 230.26M | 212.42M | 215.36M | 207.06M | 143.48M | 182.54M | 197.76M | 182.32M | 358.3M | 175.76M | 162.95M | 159.57M | 161.63M |
| Spine Revenue Growth | +104.84% | +2.21% | -2.98% | +70.48% | +35.27% | +2.09% | +2.70% | +6.49% | -1.79% | +7.75% | -3.21% | +7.23% | -9.03% | +8.40% | -1.37% | +4.01% | +44.31% | -21.40% | -7.69% | +8.46% | -49.11% | +103.86% | +7.86% | +2.12% | -1.27% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Non Us Revenue | 519.29M | 288.71M | 150.9M | 138.53M | 124.59M | 137.69M |
| Non Us Revenue Growth | +79.86% | +91.32% | +8.93% | +11.19% | -9.51% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 253.48M | 240.74M | 238.12M | 248.71M | 244.72M | 156.21M | 120.07M | 122.42M | 118.08M | 106.58M | 106.72M | 100.75M | 106.56M | 96.44M | 107.25M | 97.89M | 92.05M | 89.15M | 80.02M | 93.54M | 92.14M | 88.45M | 88.38M | 85.78M | 83.64M | 75.13M | 77.13M | 75.69M | 72.96M | 63.36M | 64.44M | 67.06M | 60.84M | 54.21M | 52.41M | 54.57M | 53.39M | 53.83M | 54.51M | 52.29M |
| Selling, General, and Administrative Revenue Growth | +5.29% | +1.10% | -4.26% | +1.63% | +56.66% | +30.10% | -1.92% | +3.68% | +10.79% | -0.13% | +5.93% | -5.45% | +10.49% | -10.08% | +9.56% | +6.35% | +3.25% | +11.41% | -14.45% | +1.52% | +4.16% | +0.09% | +3.03% | +2.56% | +11.33% | -2.59% | +1.89% | +3.75% | +15.14% | -1.67% | -3.91% | +10.22% | +12.23% | +3.43% | -3.96% | +2.21% | -0.82% | -1.24% | +4.24% | n/a |
| Research and Development Revenue | 33.41M | 35.38M | 37.7M | 44.67M | 52.25M | 29.33M | 21.35M | 21.08M | 19.51M | 18.7M | 17.39M | 17.41M | 51.02M | 15.85M | 15.55M | 14.92M | 15.24M | 14.42M | 39.45M | 15.4M | 15.5M | 14.51M | 15.75M | 14.32M | 13.76M | 15.53M | 13.52M | 12.69M | 11.41M | 10.89M | 10.71M | 10.67M | 13.64M | 10.27M | 11.25M | 10.2M | 9.84M | 9.41M | 9.08M | 8.66M |
| Research and Development Revenue Growth | -5.57% | -6.15% | -15.60% | -14.52% | +78.16% | +37.39% | +1.26% | +8.07% | +4.31% | +7.51% | -0.10% | -65.87% | +221.84% | +1.97% | +4.17% | -2.08% | +5.69% | -63.45% | +156.17% | -0.61% | +6.81% | -7.86% | +9.93% | +4.11% | -11.39% | +14.82% | +6.57% | +11.18% | +4.83% | +1.62% | +0.44% | -21.82% | +32.91% | -8.76% | +10.31% | +3.69% | +4.54% | +3.61% | +4.91% | n/a |